Abstract
Age-related wear and tear of cartilage (osteoarthritis) and traumatic cartilage damage are a leading cause of disability in developed nations. Articular (hyaline) cartilage covers the ends of the bones of synovial joints and is a complex, multilayered structure varying in composition with location in a joint, and in relation to load and shear forces at that specific site. When damaged, articular cartilage tissue does not have the ability to repair itself, but rather is usually replaced by fibrocartilage which does not have suitable compressive properties, leading to breakdown, pain and can ultimately require replacement by prosthetic joint. Thus, cartilage repair remains a clinical challenge and few current treatments yield satisfactory clinical results over the long term. Regenerative medicine, using tissue engineering-based constructs to enhance cartilage repair by mobilizing chondrogenic cells, is a promising approach for restoration of structure and function, and provides a scientific basis for integrating the proper cell populations, suitable cellular signals and appropriate scaffolds for optimum tissue development and organ replacement strategies. Fibrin has been used as both a delivery vehicle and as a scaffolding matrix for tissue engineering. The emergence of mesenchymal stem cells (MSCs) as an important tool in regenerative medicine is due to their capability to repopulate and differentiate into several tissue lineages, including both cartilage and bone. Human MSCs have been used in combination with a wide range of fibrin scaffolds including both autologous and allogeneic human fibrin glue either as a platelet-rich or normal formulation, in addition to commercially available bovine fibrin hydrogel precursors. This approach permits high density of cells to be implanted, wherein chemical manipulation of the fibrin scaffold modulates its stability, strength and complement of growth factors, while maintaining the promise of an autologous repair solution. This review focuses on recent advances in the application of the fibrinogen/fibrin system for tissue engineering of articular cartilage.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahmed TA, Hincke MT (2010) Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng Part B Rev 16:305–329
Ahmed TA, Griffith M, Hincke M (2007) Characterization and inhibition of fibrin hydrogel-degrading enzymes during development of tissue engineering scaffolds. Tissue Eng 13:1469–1477
Ahmed TA, Dare EV, Hincke M (2008) Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14:199–215
Ahmed TAE, Halpenny M, Atkins H, Giulivi A, Dervin G, Griffith M, Hincke M (2010) Stabilization of fibrin-mesenchymal stem cells (MSCs) constructs under hypoxic conditions during tissue engineering of articular cartilage. J Bone Joint Surg Br 92-B:2–3
Ahmed TA, Giulivi A, Griffith M, Hincke M (2011) Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng Part A 17:323–335
Arita NA, Pelaez D, Cheung HS (2011) Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGFbeta-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 405:564–569
Baumgartner L, Arnhold S, Brixius K, Addicks K, Bloch W (2010) Human mesenchymal stem cells: influence of oxygen pressure on proliferation and chondrogenic differentiation in fibrin glue in vitro. J Biomed Mater Res A 93:930–940
Chen CC, Liao CH, Wang YH, Hsu YM, Huang SH, Chang CH, Fang HW (2012) Cartilage fragments from osteoarthritic knee promote chondrogenesis of mesenchymal stem cells without exogenous growth factor induction. J Orthop Res 30:393–400
Dickhut A, Dexheimer V, Martin K, Lauinger R, Heisel C, Richter W (2010) Chondrogenesis of human mesenchymal stem cells by local transforming growth factor-beta delivery in a biphasic resorbable carrier. Tissue Eng Part A 16:453–464
Diederichs S, Baral K, Tanner M, Richter W (2012) Interplay between local versus soluble TGF-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A 18:1140–1150
Haleem AM, Singergy AA, Sabry D, Atta HM, Rashed LA, Chu CR, El Shewy MT, Azzam A, Abdel Aziz MT (2010) The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 1:253–261
Ho ST, Cool SM, Hui JH, Hutmacher DW (2010) The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials 31:38–47
Im GI, Shin YW, Lee KB (2005) Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13:845–853
Jung SN, Rhie JW, Kwon H, Jun YJ, Seo JW, Yoo G, Oh DY, Ahn ST, Woo J, Oh J (2010) In vivo cartilage formation using chondrogenic-differentiated human adipose-derived mesenchymal stem cells mixed with fibrin glue. J Craniofac Surg 21:468–472
Kessler MW, Grande DA (2008) Tissue engineering and cartilage. Organogenesis 4:28–32
Kupcsik L, Alini M, Stoddart MJ (2009) Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng Part A 15:2309–2313
Lee HH, Haleem AM, Yao V, Li J, Xiao X, Chu CR (2011) Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng Part A 17:1969–1978
Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ (2009) Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng Part A 15:1729–1737
Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ (2010a) Mechanical load modulates chondrogenesis of human mesenchymal stem cells through the TGF-beta pathway. J Cell Mol Med 14:1338–1346
Li Z, Yao SJ, Alini M, Stoddart MJ (2010b) Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Eng Part A 16:575–584
Park JS, Yang HN, Woo DG, Jeon SY, Park KH (2011a) Chondrogenesis of human mesenchymal stem cells in fibrin constructs evaluated in vitro and in nude mouse and rabbit defects models. Biomaterials 32:1495–1507
Park JS, Shim MS, Shim SH, Yang HN, Jeon SY, Woo DG, Lee DR, Yoon TK, Park KH (2011b) Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-beta3. Biomaterials 32:8139–8849
Pelaez D, Huang CY, Cheung HS (2009) Cyclic compression maintains viability and induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem Cells Dev 18:93–102
Pelaez D, Arita N, Cheung HS (2012) Extracellular signal-regulated kinase (ERK) dictates osteogenic and/or chondrogenic lineage commitment of mesenchymal stem cells under dynamic compression. Biochem Biophys Res Commun 417:1286–1291
Schatti O, Grad S, Goldhahn J, Salzmann G, Li Z, Alini M, Stoddart MJ (2011) A combination of shear and dynamic compression leads to mechanically induced chondrogenesis of human mesenchymal stem cells. Eur Cell Mater 22:214–225
Yang HN, Park JS, Woo DG, Jeon SY, Do HJ, Lim HY, Kim SW, Kim JH, Park KH (2011) Chondrogenesis of mesenchymal stem cells and dedifferentiated chondrocytes by transfection with SOX Trio genes. Biomaterials 32:7695–7704
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ahmed, T.A.E., Hincke, M.T. (2013). Fibrin for Encapsulation of Human Mesenchymal Stem Cells for Chondrogenic Differentiation. In: Hayat, M. (eds) Stem Cells and Cancer Stem Cells, Volume 10. Stem Cells and Cancer Stem Cells, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6262-6_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-6262-6_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6261-9
Online ISBN: 978-94-007-6262-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)